1997
DOI: 10.1007/bf02765743
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of polycystic ovary patients undergoing IVF

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1998
1998
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Pentoxifylline has anti-angiogenic effects and has been postulated to lead to endometriosis lesion regression [ 65 ]. Some studies have suggested that pentoxifylline may improve oocyte quality, fertilization rates, and embryo development in women with endometriosis [ 66 , 67 ], whereas others have found no beneficial effect on oocyte and embryo quality [ 68 , 69 ]. The effects of pentoxifylline have been evaluated in a recent Cochrane systematic review based on three randomized controlled trials in 285 patients, which showed that overall the evidence for the effect of pentoxifylline versus placebo on clinical pregnancy rates is uncertain, and there are no trials that have reported on the effects of pentoxifylline on live birth rate [ 70 ].…”
Section: Management Optionsmentioning
confidence: 99%
“…Pentoxifylline has anti-angiogenic effects and has been postulated to lead to endometriosis lesion regression [ 65 ]. Some studies have suggested that pentoxifylline may improve oocyte quality, fertilization rates, and embryo development in women with endometriosis [ 66 , 67 ], whereas others have found no beneficial effect on oocyte and embryo quality [ 68 , 69 ]. The effects of pentoxifylline have been evaluated in a recent Cochrane systematic review based on three randomized controlled trials in 285 patients, which showed that overall the evidence for the effect of pentoxifylline versus placebo on clinical pregnancy rates is uncertain, and there are no trials that have reported on the effects of pentoxifylline on live birth rate [ 70 ].…”
Section: Management Optionsmentioning
confidence: 99%